HC Andersen Capital Events 30/08: Mød topledelsen i Curasight

HC Andersen Capital afholder i dag et spændende event, hvor du kan møde og stille spørgsmål direkte til topledelsen. Det er frit for alle og gratis at deltage.

Curasight - Presentation of Q2 2023
Curasight released their half year report on Thursday August 24th, and as expected the report showed a profit before tax of DKK -16,8 million following the ongoing development of its two technology platforms uTRACE (to diagnose cancer) and uTREAT (to treat cancer).

In the latest quarter Curasight also announced a partnership with Curium relating to uTRACE for prostate cancer, and Curasight released positive pre-clinical data relating to uTREAT to treat brain cancer, and lastly positive data relating to uTRACE to diagnose brain cancer. In its report, Curasight announce they have a cash position of DKK 32,1 million.

Meet the company's CEO Ulrich Krasilnikoff and co-founder and CSO Andreas Kjær in a digital event at HC Andersen Capital on Wednesday, August 30th at 1:00 PM.

Disclaimer: HC Andersen Capital receives payment from Curasight for a DigitalIR/Corporate Visibility agreement./Henrik Ekman 15:56, 25/08-2023.

Onsdag den 30. august kl. 13:00 - 13:30

Tilmeld dig via link.
 

Mie Halse
Head of Digital and Events
mie@hcandersencapital.dk
+45 28746640
 

HC Andersen Capital digitaliserer relationen mellem børsnoterede selskaber og investorer. Vi arbejder langsigtet for selskaber, der ønsker mere synlighed i markedet. #DemocraticIR - HC Andersen Capital arbejder for at demokratisere adgangen til det finansielle marked.